Startup InPress Reports First Clinical Data For Postpartum Hemorrhage Device
This article was originally published in The Gray Sheet
Executive Summary
Data from 10 patients supports quick action to stop hemorrhages, the leading cause of perinatal maternal death. InPress Technologies hopes to launch an FDA trial later this year.
You may also be interested in...
News In Brief
Boston Scientific acquires C.R. Bard’s electrophysiology business. European Council issues a progress report on device reforms. More news in brief.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.
Metsera Launches As New Obesity Contender Flush With $290m
Clive Meanwell, former CEO of The Medicines Company, will helm the new company, backed by ARCH and other investors. He talked to Scrip about the new venture.